Revolution Medicines (RVMD) Cash from Financing Activities (2019 - 2026)
Revolution Medicines (RVMD) recorded Cash from Financing Activities of $2.42 billion in Q2 2026, up 843.4% from $256.58 million a year earlier and up 913.8% from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Cash from Financing Activities (2019 - 2026) Analysis & Trends
On a TTM basis, Revolution Medicines' Cash from Financing Activities came in at $3.02 billion as of Jun 30, 2026, up 150.2% year-over-year; for FY2025, it came in at $621.52 million, down 35.2% from FY2024.
- Annual Cash from Financing Activities has a five-year compound annual growth rate of 8.0% (FY2020 to FY2025).
- Across earlier years, Cash from Financing Activities came in at $959.41 million in FY2024 (-21.9%), $1.23 billion in FY2023 (+307.8%), $301.43 million in FY2022 (+2.5%) and $294.18 million in FY2021 (-30.4%).
- The Q2 2026 figure is the highest quarterly Cash from Financing Activities in data going back to Q1 2019.
- On a year-over-year basis, Cash from Financing Activities rose in three of the last four quarters, with growth averaging 199.3%.
- Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 843.4% in Q2 2026, against a decline of 99.9% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $238.74 million (Q1 2026), $365.66 million (Q4 2025) and -$1.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - | 2.42 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.42 Bn |
| Mar 31, 2026 | 238.74 Mn |
| Dec 31, 2025 | 365.66 Mn |
| Sep 30, 2025 | -1.59 Mn |
| Jun 30, 2025 | 256.58 Mn |
| Mar 31, 2025 | 874,000.00 |
| Dec 31, 2024 | 873.81 Mn |
| Sep 30, 2024 | 77.29 Mn |
| Jun 30, 2024 | 7.50 Mn |
| Mar 31, 2024 | 810,000.00 |
| Dec 31, 2023 | 839.35 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 64.63 Mn |
| Mar 31, 2023 | 324.21 Mn |
| Dec 31, 2022 | 51.36 Mn |
| Sep 30, 2022 | 248.34 Mn |
| Jun 30, 2022 | 1.43 Mn |
| Mar 31, 2022 | 305,000.00 |
| Dec 31, 2021 | 10.73 Mn |
| Sep 30, 2021 | 319,000.00 |
API Access
Revolution Medicines Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();